231 related articles for article (PubMed ID: 34382383)
21. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous anaplastic large cell lymphoma.
Brown RA; Fernandez-Pol S; Kim J
J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
[TBL] [Abstract][Full Text] [Related]
23. Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
Kamstrup MR; Biskup E; Gniadecki R
Br J Dermatol; 2010 Oct; 163(4):781-8. PubMed ID: 20560956
[TBL] [Abstract][Full Text] [Related]
24. CD30+ lymphoproliferative disorder in a patient with metastatic papillary thyroid carcinoma.
Udkoff J; Cohen PR
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329586
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS
Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
[TBL] [Abstract][Full Text] [Related]
26. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
27. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.
Kempf W; Kazakov DV; Paredes BE; Laeng HR; Palmedo G; Kutzner H
Dermatology; 2013; 227(4):346-52. PubMed ID: 24246691
[TBL] [Abstract][Full Text] [Related]
29. Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.
Nasit JG; Patel SC
Indian J Dermatol; 2015; 60(4):373-7. PubMed ID: 26288406
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
31. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.
Xerri L; Adélaïde J; Avenin M; Guille A; Taix S; Bonnet N; Carbuccia N; Garnier S; Mescam L; Murati A; Chaffanet M; Coso D; Bouabdallah R; Bertucci F; Birnbaum D
Histopathology; 2019 Mar; 74(4):654-662. PubMed ID: 30393995
[TBL] [Abstract][Full Text] [Related]
32. SATB1 Defines a Subtype of Cutaneous CD30
Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
[TBL] [Abstract][Full Text] [Related]
33. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous anaplastic large-cell lymphoma: a case report.
Cao C; Zeng K; Wang M; Han K; Peng Y; Xiong H; Wang Q; Li Q; Wang Q; Li L
Dermatol Ther; 2016 Jul; 29(4):224-7. PubMed ID: 26970422
[TBL] [Abstract][Full Text] [Related]
35. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
Davick JJ; Mutgi KAJ; Wanat KA; Link BK; Liu V
J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
Tomaszewski MM; Moad JC; Lupton GP
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
Sigel JE; Hsi ED
Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
[TBL] [Abstract][Full Text] [Related]
38. [Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Sumitani R; Harada T; Nakamura M; Mizuguchi M; Oura M; Sogabe K; Maruhashi T; Takahashi M; Fujii S; Nakamura S; Miki H; Kagawa K; Yada M; Matsudate Y; Uehara H; Abe M
Rinsho Ketsueki; 2022; 63(6):536-543. PubMed ID: 35831185
[TBL] [Abstract][Full Text] [Related]
39. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
Martires KJ; Ra S; Abdulla F; Cassarino DS
Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
[TBL] [Abstract][Full Text] [Related]
40. Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.
Cornejo CM; Novoa RA; Krisch RE; Kim EJ
Cutis; 2016 Oct; 98(4):253-256. PubMed ID: 27874877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
